Immatics N.V. (IMTX) stock
IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.29+0.12 (+1.94%)
Close on Nov 17, 2026Market cap $843.31MP/E –Yield –
Immatics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Immatics's operating cash flow for the twelve months ending Dec 31, 2024 was -€158.03M. For fiscal 2025 it was -€176.63M. The highest annual figure on record is €100.13M in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -€176.63M | – |
| FY2024 | Dec 31, 2024 | -€158.03M | -967.0% |
| FY2023 | Dec 31, 2023 | €18.23M | -81.8% |
| FY2022 | Dec 31, 2022 | €100.13M | – |
| FY2021 | Dec 31, 2021 | -€84.75M | – |
| FY2020 | Dec 31, 2020 | -€80.70M | -213.7% |
| FY2019 | Dec 31, 2019 | €70.97M | +243.1% |
| FY2018 | Dec 31, 2018 | €20.68M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -€58.48M | – |
| Q3 FY2024 | Sep 30, 2024 | -€33.73M | – |
| Q2 FY2024 | Jun 30, 2024 | -€33.22M | – |
| Q1 FY2024 | Mar 31, 2024 | -€32.61M | – |
| Q2 FY2020 | Jun 30, 2020 | -€16.29M | – |
| Q1 FY2020 | Mar 31, 2020 | -€11.45M | – |
See a number that looks wrong?